Agricultural pest infestation is as old as domestication of food crops and contributes a major 24 share to the cost of crop production. Transgenic production of Vip3A, an insecticidal protein 25 from Bacillus thuringiensis, effectively controls lepidopteran pests. A synthetic vip3A gene was 26 evaluated its efficacy against Spodoptera litura (cotton leafworm), Spodoptera exigua (beet 27 armyworm), Spodoptera frugiperda (fall armyworm), Helicoverpa armigera (cotton bollworm), 28 Helicoverpa zea (corn earworm), Heliothis virescens (tobacco budworm), and Manduca sexta 29 (tobacco hornworm). In artificial diet assays, the Vip3A concentration causing 50% mortality 30 was H. zea > H. virescens > S. exigua > H. armigera > M. sexta > S. frugiperda > S. litura. In 31 contrast, on vip3A transgenic tobacco the order of resistance (time until 50% lethality) was M. 32 sexta > H. virescens > S. litura > H. zea > H. armigera > S. exigua > S. frugiperda. There was 33 no significant correlation between the artificial diet and transgenic tobacco effects. Notably, the 34 two insect species that are best-adapted for growth on tobacco, M. sexta and H. virescens, 35 showed the greatest tolerance of vip3A-transgenic tobacco. This may indicate synergistic effects 36 of Vip3A and endogenous plant defense mechanisms, e.g. nicotine, to which M. sexta and H. 37 virescens would have greater resistance. Together, our results show that artificial diet assays are 38 a poor predictor of Vip3A efficacy in transgenic plants, lepidopteran species vary in their 39 sensitivity to Vip3A in diet-dependent manner, and that host plant adaptation of the targeted 40 herbivores should be considered when designing transgenic plants for pest control.
Abstract:
Introduction population. Cross-resistance to Cry1Ac and Cry2Ab δ-endotoxins, which share the same binding 24 site in the midgut epithelial membrane of insects, may also facilitate the development of 25 resistance (Estela et al. 2004) . Thus, there is a need to implement new toxins and develop new 26 approaches that will provide safe, reliable, and robust control of insect pests. 27 Vegetative insecticidal proteins (Vip), another class of toxins isolated from B. 28 thuringiensis, have the potential to provide better broad-spectrum protection against insect pests 29 than the more commonly implemented Cry δ-endotoxins (Lemes et al. 2017) . The Bt Toxin 30 Nomenclature Committee has classified Vip proteins into four families, Vip1, Vip2, Vip3 and 31 Vip4. Whereas Vip1 and Vip2 are binary toxins with good activity against coleopteran pests,
32
Vip3 proteins are single-chain toxins targeting a wide variety of lepidopteran species. Vip4 33 toxins have as yet unknown toxicity and host range, although Vip4Aa1 is phylogenetically 34 similar to Vip1 proteins (Gayen et al. 2012 , Palma et al. 2014 . Vip3A is notable for its 35 effectiveness against Spodoptera and Helicoverpa spp., which are commonly resistant to Cry 36 toxins. Relative to other Bt toxins, which require high doses to control pest populations, Vip3A 37 shows strong growth inhibition even at lower concentrations (Chakroun et al. 2016a) . Therefore,
38
Vip3A toxins can provide effective control of insects that are resistant to the Cry toxins. 39 The first Vip3 genes were cloned as vip3Aa1 and Vip3Ab1 from the DNA libraries of B. 40 thuringiensis strains AB424 and AB88, respectively (Estruch et al. 1996) . Vip3Aa gene has been 41 successfully introduced into both cotton and maize (Kurtz et al. 2007 , Burkness et al. 2010 . 42 Later, this gene was stacked with other cry genes to provide a wider insecticidal spectrum and 43 prolong resistance against pests in the field. Two commercialized varieties, VipCot ® (Vip3Aa19 44 transformation event COT102 in cotton) and Agrisure Viptra ® (Vip3Aa20 transformation event 45 MIR612 in maize) were registered in the United States in 2008 and 2009, respectively, by 46 Syngenta Seeds. Both events were pyramided with cry1Ab as (VipCot+cry1Ab) and (Agrisure 47 Viptra+cry1Ab) to provide wider and more robust protection against lepidopteran pests.
48
Furthermore, corn event MIR162 has been also stacked with Cry3 toxin (Cry3A and eCry3.1Ab) 49 to confer resistance against coleopteran pests (Carrière et al. 2015) . Similarly, Bollgard ® III 50 (harboring Vip3A(a), Cry1Ac and Cry2Ab2) was registered in Japan in 2014. More recently, 51 synthetic gene technology has been utilized to localize and enhance the expression of insecticidal 52 genes in several crops. For instance, cotton has been transformed with synthetic Vip3A fused to 53 a chloroplast transit peptide, resulting in high Vip3A accumulation in the chloroplasts and 54 causing 100% mortality in neonates of S. frugiperda, S. exigua and H. zea caterpillars (Wu et al. 55 2011). 56 In this study, we designed and synthesized a codon-optimized vip3A gene and determined 57 the relative efficacy of the encoded protein against lepidopteran pests, both in vitro and in 58 transgenic tobacco (Nicotiana tabacum) plants. Both purified Vip3A protein and transgenic 59 tobacco plants showed toxicity in experiments with Spodoptera litura (cotton leafworm),
60
Spodoptera exigua (beet armyworm), Helicoverpa armigera (cotton bollworm), Helicoverpa zea 61 (corn earworm), Heliothis virescens (tobacco budworm), and Manduca sexta (tobacco 62 hornworm). However, Vip3A toxicity in artificial diet did not correlate with toxicity in 63 transgenic tobacco, suggesting that there are synergistic effects between endogenous tobacco 64 defenses and Vip3A.
Materials and Methods

70
Design of synthetic vip3A 71 The vip3A gene sequence (accession AY074706.1) was retrieved from the National Center for 72 Biotechnology Information (https://www.ncbi.nlm.nih.gov) nucleotide database and was codon 73 optimized by using Geneious 8.0 software (www.genious.com) and a Gossypium spp. codon 74 usage table (http://www.kazusa.or.jp). This codon-optimized vip3A gene was synthesized by 75 ATUM (formerly DNA 2.0, Newark, California, USA) and cloned into the vector pCR-Blunt 76 (5.5 kbp) (Life Technologies, Carlsbad, CA). The nucleotide sequence data of the synthetic 77 vip3A gene was submitted to GenBank (accession MK761073).
78
Development of vip3A gene constructs 79
The synthetic vip3A gene (~2.4 kbp) was enzymatically digested from pCR-Blunt using PstI and 
84
Further, the synthetic vip3A gene cassette was cloned in the plant expression vector 85 pGA482 (~11.2 Kbp) (An 1986). The gene cassette was amplified by PCR, with KpnI and ClaI 86 restriction sites were introduced at the 5` and 3` ends of the forward and reverse primers 87 (Supplemental Table 2 ), respectively. The amplified PCR product was cloned into KpnI and 88 ClaI sites of pGA482. The resulting plasmid was confirmed by restriction analysis and named as 89 pMHK-98 (Supplemental Figure 1C ).
90
For protein purification, the synthetic vip3A gene was amplified by PCR with primers 91 having an NdeI restriction site at the 5` end of forward primer and a SalI restriction site at the 3` 92 end of reverse primer ( Supplemental Table S2 ). The PCR product cloned in the corresponding 93 restriction sites of the pET28a + vector (EMD Biosciences, San Diego, CA). The resulting 94 plasmid was named as pMHK-007 and was confirmed by restriction analysis (Supplemental 95 Figure 1D ).
96
Vip3A protein purification from an Escherichia coli expression system 97 The confirmed pMHK-007 plasmid was transformed into Escherichia coli strain BL21(DC3) and 98 transformants were selected using kanamycin (50mg/L) on lysogeny broth (LB) agar plates.
99
Cells were cultured in overnight at 37 °C in LB with (50mg/L) kanamycin, diluted 1:25, and To assess the expression of synthetic vip3A gene at the mRNA level, total RNA of transgenic 141 plants was extracted using TRIzol reagent (Invitrogen) following the manufacturer's instructions. Figure 2H depicts a time course analysis of insect 230 mortality at the highest tested Vip3A concentration for each species. The LC50 was calculated for 231 each insect species (Table 1 ). In the case of H. zea the LC50 estimate is a less accurate 232 extrapolation based on linear regression, as fewer than 50% of the insects died at the highest 233 tested Vip3A concentration. Overall, Vip3 resistance of the insects on artificial diet was in the Table   247 1). Any regenerated plant from an inoculated explant that established a well-defined root system 248 on rooting medium was considered as an independent event. All of the transgenic lines were 249 recovered and successfully shifted to pots containing sterilized sand. Figure 3B, lanes 2-6) , whereas no amplification was observed in the un-256 transformed control ( Figure 3B, lane 1) . Similarly, amplification of a correctly sized fragment of 257 ~253 bp, validates the integration of nptII gene from the five T0 transgenic lines ( Figure 3C , 258 lanes 2-6), while no amplification was observed in the untransformed control ( Fig 3C; lane 1) .
259
Moreover, for segregation studies, the presence of the vip3A gene was confirmed by PCR 260 amplification of a correctly sized fragment of ~267 bp, from genomic DNA isolated from the T1 261 generation ( Figure 3D, lanes 2-6) . 
268
Southern blots for the synthetic vip3A transgenic tobacco plants showed one or more 269 integration events of the vip3A transgene in the tobacco genome ( Figure 3F ). There are two 270 copies of the transgene in V-10, V-16 and V-20, whereas V-04 and V-11 have only a single copy 271 of the transgene. Forty seeds from each line of T0 transgenic line were grown on selection 272 medium, along with wildtype control seeds. The germinated seeds were counted after 10 days. A 273 chi-squared test showed that the frequency of kanamycin-resistant T1 progeny was more similar 274 to 3:1, which would be expected if there is one insertion, than to 15:1, which would be expected 275 if there were two insertions ( Supplemental Table 3 ). Thus, the multiple insertions evident from 276 Figure 3F are likely to be closely linked tandem insertions of the transgenic construct. Table 4 ). In the T1 generation, the calculated LT50 values, in order of highest to lowest resistance, 290 were M. sexta (10.08 ± 4.86 days), H. virescens (5.36 ± 1.88 days), S. litura (2.95 ± 0.19 days), Comparison of in vitro and in planta Vip3A bioassays 297 The LC50 and EC50 in Vip3A artificial diet assays bioassays with the seven tested lepidopteran 298 species are highly correlated ( Figure 6A ). However, comparison of LC50 and EC50 on artificial 299 diet with the LT50 for survival on transgenic vip3A tobacco showed no significant correlation 300 ( Figure 6B, C) . study was modified by optimizing codons to those preferably used by cotton. As transformation 320 of cotton is relatively expensive and time-consuming, we tested the insect-killing efficacy of our 321 synthetic vip3A gene in transgenic tobacco.
322
In our initial experiments, we observed variable efficacy of purified Vip3A protein 323 against seven lepidopteran herbivores. Not surprisingly, the lethal concentration (LC50) and 324 effective dose (EC50) for Vip3A were highly correlated ( Figure 6A) . Two of the Spodoptera 325 species, S. litura and S. frugiperda, were the most sensitive to purified Vip3A. In contrast, H. zea 326 was quite resistant to Vip3A in artificial diet.
327
Similar to the diet assays, we observed variable effectiveness in insect bioassays with T0 328 and T1 vip3A transgenic tobacco plants. In the T1 generation, 100% mortality of H. armigera, H. 329 zea and S. exigua was achieved in most of the transgenic lines after 72-120 hours of feeding.
330
Higher levels of mortality were observed for H. armigera and S. litura in the T1 than in the T0 331 generation of vip3A-transgenic tobacco. This could be due to the selection of stronger transgenic 332 lines in the T1 generation, different plant growth conditions, or variation in the insects that were 333 used at different times in the two assays. Manduca sexta and H. virescens showed lower 334 mortality after five days on transgenic tobacco than the other five tested insect species.
335
The level of Vip3A resistance (time to 50% mortality) observed in the tobacco bioassays 336 was not correlated with the diet assays (Figure 6 B, C) . Whereas H. zea was quite resistant in the 337 diet assay, all of the larvae of this species had died after 120 hours of feeding on vip3A-338 transgenic leaves. A similar dichotomy was observed with S. exigua and H. armigera, which 339 were relatively more resistant to Vip3A in diet than in transgenic tobacco. Two species, M. sexta 340 and H. virescens had relatively good resistance on vip3A transgenic tobacco, LT50 of 10.08 ± and 341 5.36 ± 1.88 days, respectively, compared to the toxicity of Vip3A in artificial diet assays. The 342 difference in lepidopteran mortality between the diet and plant assays suggests that there are 343 other factors that act synergistically with Vip3A to cause insect mortality. Relative to the other 344 five tested species, M. sexta and H. virescens are better-adapted to feeding from tobacco and are 345 likely more resistant to tobacco defenses. Thus, the relatively low level of mortality of these two 346 species on Vip3A tobacco ( Figure 5 ) could be explained by synergies between the host plant 347 defenses, e.g. nicotine and protease inhibitors, and Vip3A, leading to higher mortality of the 348 other species. However, another possibility is that some components of the artificial diet may 349 have synergistic negative effects on lepidopteran larvae in conjunction with Vip3A, thereby also 350 leading to the observed poor correlation between artificial diet and transgenic plant assays.
351
Together, our results show that a novel synthetic Vip3A toxin provides a broad-352 spectrum insecticidal activity against important lepidopteran pests feeding on transgenic plants.
353
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